My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Pfizer (NY:PFE)

27.37 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EST, Feb 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Pfizer

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

39 40 Next >

Pfizer’s Elranatamab Receives FDA and EMA Filing Acceptance

February 22, 2023

From Pfizer Inc.

Via Business Wire

What Are Dividend Payment Dates?

February 21, 2023

What are dividend payment dates? The payment date is the day a company pays its eligible shareholders dividends. Learn more.

Via MarketBeat

U.S. FDA Accepts Biologics License Application for Pfizer’s Respiratory Syncytial Virus Maternal Vaccine Candidate for Priority Review

February 21, 2023

From Pfizer Inc.

Via Business Wire

Bladder Prolapse (Cystocele) Market to Touch at High CAGR of 8.3% by 2022-2029

February 20, 2023

Bladder Prolapse (cystocele) Market is expected to grow at a CAGR of 8.3 % during the forecast period (2022-2029).

Via SBWire

Salivary Gland Cancer Treatment Market Outlook Growth Share Overview Analysis 2022-2029

February 17, 2023

Global Salivary Gland Cancer Treatment Market to Witness Huge Growth by Key Players: Bristol-Myers Squibb Company, LGM PHARMA, Pfizer Inc., Bedford Laboratories, Baxter, sanofi-aventis U.S. LLC, Pierre...

Via SBWire

Choroidal Neovascularization Market Share Size Trends Overview Analysis 2022-2029

February 16, 2023

Global Choroidal Neovascularization Market to Witness Huge Growth by Key Players: Bausch Health Companies Inc, Bayer AG, Gilead Sciences Inc, F.Hoffmann –La Roche AG,MaaT Pharma Novartis AG, Pfizer...

Via SBWire

Occupational Medicines Market Is Expected to Reach at High CAGR of 5.4% by 2022-2029

February 16, 2023

Occupational medicines market size was worth US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 5.4 % during the forecast period (2022-2029).

Via SBWire

Zoetis, Pet-Med Specialist, Double-Digit Earnings Growth Ahead

February 16, 2023

Animal health company Zoetis is up 7.99% in the past week, after topping fourth-quarter views. Analysts see double-digit EPS growth in 2023 and 2024.

Via MarketBeat

Pfizer Announces Positive TALZENNA® and XTANDI® Combination Data from Phase 3 TALAPRO-2 Study

February 16, 2023

From Pfizer Inc.

Via Business Wire

Pfizer Announces The Lancet Neurology Has Published Phase 3 Data for Zavegepant for the Acute Treatment of Migraine in Adults

February 16, 2023

From Pfizer Inc.

Via Business Wire

Ziprasidone Market Trends Share Demand Overview Analysis 2022-2029

February 14, 2023

Global Ziprasidone Market to Witness Huge Growth by Key Players: Pfizer Inc., Sandoz AG, Lupin Pharmaceuticals, Inc., Mylan Pharmaceuticals, Apotex, Dr. Reddy's laboratories Ltd., Wockhardt, Aurobindo...

Via SBWire

Spinal Stenosis Treatment Market to Grow with a Growth Rate of 4% During 2022 to 2029

February 14, 2023

Spinal Stenosis Treatment Market size was valued USD million in 2021 and is estimated to reach USD million by 2029, growing at a CAGR of 4% during the forecast period (2022-2029).

Via SBWire

Undifferentiated Pleomorphic Sarcoma Therapeutics Market Share Volume Demand 2022 to 2029

February 14, 2023

The Undifferentiated Pleomorphic Sarcoma Therapeutics Market size was valued USD million in 2021 and is estimated to reach USD million by 2029, growing at a high CAGR during the forecast period...

Via SBWire

Water for Injection Market Trends Outlook Demand 2023 -2030

February 13, 2023

Global Water for Injection Market to Witness Huge Growth by Key Players: Abbott Laboratories, AdvaCare Pharma, B. Braun SE, FUJIFILM Holdings Corp., GlaxoSmithKline Plc, Merit Healthcare International...

Via SBWire

FDA Approves Pfizer's Supplemental New Drug Application for CIBINQO® (abrocitinib)

February 10, 2023

From Pfizer Inc.

Via Business Wire

Gemcitabine HCL Market to Grow with a Growth Rate of 7% During 2023 to 2030

February 10, 2023

Gemcitabine HCL Market size is expected to reach at a CAGR of 7% during the forecast period (2023-2030).

Via SBWire

BioRestorative Therapies Inc (NASDAQ: BRTX) Announces European Patentability Of ThermoStem® Program With Indications In Obesity And Type 2 Diabetes

February 10, 2023

By Julian Richard, Benzinga

Via TheNewswire.com

Topics Intellectual Property

Europe Liver Cancer Therapeutics Market to Reach at High CAGR of 8.95% by 2023-2030

February 09, 2023

The Europe liver cancer therapeutics size was valued at US$ 384 million in 2022 and is estimated to reach US$ 627 million by 2030, growing at a CAGR of 8.95% during the forecast period (2023-2030)

Via SBWire

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

February 09, 2023

From Pfizer Inc.

Via Business Wire

Musculoskeletal Diseases Treatment Market Is Poised to Cross at High CAGR of 4.9% in 2023-2030

February 08, 2023

The Musculoskeletal Diseases Treatment Market size was valued at US$ YY million in 2023 and is estimated to reach US$ YY million by 2030, growing at a CAGR of 4.8% during the forecast period...

Via SBWire

Pain Relief Medication Market to Witness Huge Growth by Key Players: Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Sanofi S.A., GlaxoSmithKline Plc.

February 08, 2023

Global Pain Relief Medication Market By Material (Acute, Chronic), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)

Via SBWire

Active Pharmaceutical Ingredients Market May Set Epic Growth Story : Pfizer, Novartis, Sanofi

February 07, 2023

Stay up-to-date with Active Pharmaceutical Ingredients Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.

Via SBWire

Topics Death

February 03, 2023

Via SBWire

Topics Intellectual Property

Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?

February 02, 2023

Can gains in Tesla, Zoom, Exact Sciences, and other growth stocks set the stage for Cathie Woods' Ark Innovation Fund to stage a comeback in 2023?

Via MarketBeat

Topics ETFs

Novavax Shares Jumped in January While Others Slipped

February 01, 2023

Updated FDA Covid vaccine policy could've boosted NVAX shares at the end of January, when other pharma stocks slipped, but it may not affect the bottom line.

Via MarketBeat

Pfizer Stock: What the Bulls and Bears are Getting Wrong

February 01, 2023

Pfizer stock is bouncing up and down after mixed Q4 earnings. There's been an emotional battle between bulls and bears but it's time for both to get rational

Via MarketBeat

PFIZER REPORTS RECORD FULL-YEAR 2022 RESULTS AND PROVIDES FULL-YEAR 2023 FINANCIAL GUIDANCE

January 31, 2023

From Pfizer Inc.

Via Business Wire

MarketBeat Week in Review – 1/23- 1/27

January 28, 2023

Markets were pushing hard to continue the rally as.recession fears and layoff announcements offset two data points that suggest inflation may be easing

Via MarketBeat

Topics Economy Workforce

How Could GSK's RSV Vaccine Change its Valuation?

January 26, 2023

GSK's RSV vaccine could be a good earner for the company, according to outside analysts and its own predictions for the future.

Via MarketBeat

Is the Pain Over for Baudax Bio Investors after a 70% Spike?

January 25, 2023

Baudax Bio (NASDAQ: BXRX) shares spiked as much as 70% on its announcement of positive interim phase 2 clinical trials for its pain medicine BX1000.

Via MarketBeat

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

39 40 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.